Cleanse skin thoroughly before applying product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
FLAMMABLE : Keep away from spark, heat or flame.
Salicylic acid 2.0%
Acne Medication
Uses • For the treatment of acne.
For external use only.
FLAMMABLE: Keep away from spark, heat or flame.
When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Other information
May stain some fabrics.
alcohol denat., ammonium hydroxide, benzalkonium chloride, butylene glycol, C12-15 alkyl lactate, C13-14 isoparaffin, capryloyl glycine, cedrus atlantica bark extract, cetyl lactate, cinnamomum zeylanicum bark extract, cocamidopropyl PG-dimonium chloride phosphate, cyclopentasiloxane, dehydroxanthan gum, ethylparaben, fragrance, glycerin, hamamelis virginiana (witch hazel) extract, hexylene glycol, laureth-7, methylparaben, phenethyl dimethicone, phenoxyethanol, polyacrylamide, polysorbate 20, portulaca oleracea extract, PPG-2 isoceteth-20 acetate, propylparaben, sarcosine, tetrasodium EDTA, water
Meijer Acne Spot Treatment Oil Free
1 tube in a carton
0.75 FL OZ (22.1)
NDC 41250-956-51
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41250-956 | 41250-956-51 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f4ad0cad-afdf-0afe-e053-2a95a90a5a94 | 8ef9e4bf-04ee-44ad-e053-2995a90aa5b3 | 2023-02-14 | Warnings | 8ef9e4bf-04ee-44ad-e053-2995a90aa5b3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.